4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-21-000080
President and CEO sold 18,333 shares at an average $51.41 ($942,477)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-02 | Sale : show line 1 in the form | −8,543 | $50.80 | $433,984 | 2,183,866 | I |
| 2021-08-02 | Sale : show line 2 in the form | −9,790 | $51.94 | $508,493 | 2,174,076 | I |
| Open-market sales · 18,333 sh · avg $51.41 · $942,477 | ||||||
Loading xslF345X03/wf-form4_162811883181212.xml…